Dose-finding Study for the Ultralow-dose Levonorgestrel Intrauterine Contraceptive System (LCS)

PHASE2CompletedINTERVENTIONAL
Enrollment

742

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Contraception
Interventions
DRUG

Levonorgestrel IUS (BAY86-5028, G04209B)

Levonorgestrel intrauterine contraception system (IUS) releasing 12 microg/24 h in vitro, to be used for three years

DRUG

Levonorgestrel IUS (BAY86-5028, G04209C)

Levonorgestrel intrauterine contraception system (IUS) releasing 16 microg/24 h in vitro, to be used for three years

DRUG

Levonorgestrel IUS (Mirena, BAY86-5028)

Levonorgestrel Intrauterine contraception system (IUS) releasing 20 microg/24 h to be used for three years

Trial Locations (35)

1411

Kolbotn

2403

Elverum

3001

Drammen

3264

Larvik

3300

Eger

4400

Nyíregyháza

5600

Békéscsaba

6725

Szeged

7014

Trondheim

14186

Huddinge

15110

Lahti

20100

Turku

20520

Turku

20540

Turku

33100

Tampere

39231

Kalmar

40620

Jyväskylä

48100

Kotka

70110

Kuopio

80100

Joensuu

90100

Oulu

90185

Umeå

90220

Oulu

90570

Oulu

02100

Espoo

00100

Helsinki

0309

Oslo

411 35

Gothenburg

972 33

Luleå

602 22

Norrköping

701 46

Örebro

S-171 76

Stockholm

S40 4TF

Chesterfield

S1 2PJ

Sheffield

S40 1SX

Chesterfield

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Bayer

INDUSTRY